Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 26;12(1):183.
doi: 10.1186/s13148-020-00981-8.

Epigenetic modification mechanisms involved in keloid: current status and prospect

Affiliations
Review

Epigenetic modification mechanisms involved in keloid: current status and prospect

Wenchang Lv et al. Clin Epigenetics. .

Abstract

Keloid, a common dermal fibroproliferative disorder, is benign skin tumors characterized by the aggressive fibroblasts proliferation and excessive accumulation of extracellular matrix. However, common therapeutic approaches of keloid have limited effectiveness, emphasizing the momentousness of developing innovative mechanisms and therapeutic strategies. Epigenetics, representing the potential link of complex interactions between genetics and external risk factors, is currently under intense scrutiny. Accumulating evidence has demonstrated that multiple diverse and reversible epigenetic modifications, represented by DNA methylation, histone modification, and non-coding RNAs (ncRNAs), play a critical role in gene regulation and downstream fibroblastic function in keloid. Importantly, abnormal epigenetic modification manipulates multiple behaviors of keloid-derived fibroblasts, which served as the main cellular components in keloid skin tissue, including proliferation, migration, apoptosis, and differentiation. Here, we have reviewed and summarized the present available clinical and experimental studies to deeply investigate the expression profiles and clarify the mechanisms of epigenetic modification in the progression of keloid, mainly including DNA methylation, histone modification, and ncRNAs (miRNA, lncRNA, and circRNA). Besides, we also provide the challenges and future perspectives associated with epigenetics modification in keloid. Deciphering the complicated epigenetic modification in keloid is hopeful to bring novel insights into the pathogenesis etiology and diagnostic/therapeutic targets in keloid, laying a foundation for optimal keloid ending.

Keywords: DNA methylation; Epigenetic modification; Histone modification; Keloid; ncRNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schematic diagram of miRNA biogenesis and regulatory signaling pathways. MiRNAs are endogenous single-stranded RNAs with lengths of approximately 18–22 nucleotides. In the synthesis process of miRNAs, various enzymes are involved, including RNA polymerase, Drosha and Dicer enzymes, and Exportin-5 protein (a transporter protein). The pivotal role of mature miRNAs in regulating signaling pathways through binding to the 3′ untranslated region of the target mRNA, including PI3K/AKT signaling pathway and TGF-β signaling pathway. GTP: guanosine triphosphate; miRNA: microRNA; TRBP: TAR RNA binding protein
Fig. 2
Fig. 2
Illustration of the main epigenetic mechanisms (DNA methylation, histone modifications, and ncRNAs) involved in the regulation of keloid progression including aberrant proliferation, myofibroblast activation, apoptosis, cell cycle, migration, and collagen production. DNMT: DNA methyltransferase; TET ten-eleven translocation, 5mC 5-methylated cytosine, 5fC 5-formylcytosine cytosine, 5-hmC 5-hydroxymethylated cytosine, 5caC 5-carboxylcytosine cytosine, TDG thymine DNA glycosylase, me methylation, ac acetylation, pho phosphorylation, ub ubiquitination, sum sumoylation

Similar articles

Cited by

References

    1. Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020;8:360. doi: 10.3389/fcell.2020.00360. - DOI - PMC - PubMed
    1. Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci. 2018;19(3):711. doi: 10.3390/ijms19030711. - DOI - PMC - PubMed
    1. Saveria Fioretto B, Rosa I, Romano E, Wang Y, Guiducci S, Zhang G, Manetti M, Matucci-Cerinic M. The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview. Ther Adv Musculoskelet Dis. 2020;12:1759720X20918456. doi: 10.1177/1759720X20918456. - DOI - PMC - PubMed
    1. Kim JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci. 2009;66(4):596–612. doi: 10.1007/s00018-008-8432-4. - DOI - PMC - PubMed
    1. Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015;30(9):1033–1057. - PubMed

Publication types

MeSH terms

LinkOut - more resources